Position in MDT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,016,345
-$35,592 QoQ
Shares Held
23,270
+8.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MDT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Smartleaf Asset Management LLC holds $11,982,911 across 49 Medical Devices names. MDT ranks #3 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
29,785 | $3,058,025 | |
| 2 | SYK |
Stryker Corp
|
7,995 | $2,627,077 | |
| 3 | MDT |
Medtronic plc
This page
|
23,270 | $2,016,345 | |
| 4 | BSX |
Boston Scientific Corp
|
21,744 | $1,364,436 | |
| 5 | EW |
Edwards Lifesciences Corp
|
6,165 | $493,693 | |
| 6 | PHG |
Koninklijke Philips NV
|
14,841 | $406,643 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,290 | $234,182 | |
| 8 | STE |
STERIS plc
|
879 | $194,373 |
All Filings in MDT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,016,345 | 23,270 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,051,937 | 21,361 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,835,751 | 19,275 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,235,198 | 14,170 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,478,197 | 16,450 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,199,877 | 15,021 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,232,060 | 13,685 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $882,890 | 11,217 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $817,554 | 9,381 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $351,680 | 4,269 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||